Hofer & Associates
ELV icon

Hofer & Associates’s Elevance Health ELV Stock Holding History

Hofer & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-3,668
Closed -$1.42M – 96
2026
Q2 		$1.42M Sell
3,668
-108
-3% -$40.1K 0.69% 29
2026
Q1 		$1.11M Buy
3,776
+40
+1% +$13.1K 0.59% 31
2025
Q4 		$1.31M Buy
3,736
+2
+0.1% +$676 0.69% 29
2025
Q3 		$1.21M Sell
3,734
-225
-6% -$70K 0.69% 30
2025
Q2 		$1.54M Sell
3,959
-369
-9% -$148K 0.96% 26
2025
Q1 		$1.88M Buy
4,328
+83
+2% +$33.3K 1.28% 24
2024
Q4 		$1.57M Hold
4,245
– – 1.05% 25
2024
Q3 		$2.21M Sell
4,245
-84
-2% -$44.9K 1.52% 21
2024
Q2 		$2.35M Buy
4,329
+3
+0.1% +$1.59K 1.82% 20
2024
Q1 		$2.24M Sell
4,326
-59
-1% -$29.3K 1.89% 19
2023
Q4 		$2.07M Buy
4,385
+146
+3% +$67.5K 1.92% 17
2023
Q3 		$1.85M Buy
4,239
+69
+2% +$31.3K 1.89% 17
2023
Q2 		$1.85M Buy
4,170
+267
+7% +$123K 1.78% 18
2023
Q1 		$2M Hold
3,903
– – 2% 16
2022
Q4 		$2M Sell
3,903
-15
-0.4% -$7.62K 2% 17
2022
Q3 		$1.78M Hold
3,918
– – 1.91% 18
2022
Q2 		$1.89M Hold
3,918
– – 1.97% 18
2022
Q1 		$1.92M Buy
3,918
+1,804
+85% +$825K 1.69% 18
2021
Q4 		$980K Buy
+2,114
New +$889K 0.89% 21

Other funds holding ELV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Focused Investors
Focused Investors Los Angeles, California $2.41B AUM 10.28% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Hofer & Associates's ELV Position: Q3 2026 in Review

Hofer & Associates sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 3,668 shares — an estimated $1.42M sold.

Hofer & Associates first reported a position in ELV in Q4 2021 and held it in 19 quarters. The position peaked at $2.35M in Q2 2024. 595 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Hofer & Associates reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
  • Hofer & Associates sold 3,668 Elevance Health shares in Q3 2026, an estimated $1.42M.
  • Hofer & Associates first reported a position in Elevance Health in Q4 2021 and held it in 19 quarters.
  • Hofer & Associates's Elevance Health position peaked at $2.35M in Q2 2024.
  • 595 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Hofer & Associates's 13F filing for Q3 2026, filed 13 Oct 2026.